Real‐time field‐programmable gate array‐based closed‐loop deep brain stimulation platform targeting cerebellar circuitry rescues motor deficits in a mouse model of cerebellar ataxia
CNS Neuroscience & Therapeutics · 2024
DOI: 10.1111/cns.14638 ↗Kurz gefasst
Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, 2024. Verfasst von Gajendra Kumar und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuroscience, City University of Hong Kong, Hong Kong, Hong Kong SAR. Hauptthemen laut MEDLINE: Cerebellar Ataxia, Deep Brain Stimulation, Movement Disorders. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Innovation and Technology Commission of the Hong Kong Special Administrative Region Government.
Abstract (Originalsprache)
Aims
The open‐loop nature of conventional deep brain stimulation (DBS) produces continuous and excessive stimulation to patients which contributes largely to increased prevalence of adverse side effects. Cerebellar ataxia is characterized by abnormal Purkinje cells (PCs) dendritic arborization, loss of PCs and motor coordination, and muscle weakness with no effective treatment. We aim to develop a real‐time field‐programmable gate array (FPGA) prototype targeting the deep cerebellar nuclei (DCN) to close the loop for ataxia using conditional double knockout mice with deletion of PC‐specific LIM homeobox (Lhx)1 and Lhx5, resulting in abnormal dendritic arborization and motor deficits.
Methods
We implanted multielectrode array in the DCN and muscles of ataxia mice. The beneficial effect of open‐loop DCN‐DBS or closed‐loop DCN‐DBS was compared by motor behavioral assessments, electromyography (EMG), and neural activities (neurospike and electroencephalogram) in freely moving mice. FPGA board, which performed complex real‐time computation, was used for closed‐loop DCN‐DBS system.
Results
Closed‐loop DCN‐DBS was triggered only when symptomatic muscle EMG was detected in a real‐time manner, which restored motor activities, electroencephalogram activities and neurospike properties completely in ataxia mice. Closed‐loop DCN‐DBS was more effective than an open‐loop paradigm as it reduced the frequency of DBS.
Conclusion
Our real‐time FPGA‐based DCN‐DBS system could be a potential clinical strategy for alleviating cerebellar ataxia and other movement disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neuroscience, City University of Hong Kong, Hong Kong, Hong Kong SAR.
- Department of Biomedical Engineering, City University of Hong Kong, Hong Kong, Hong Kong SAR.
- School of Life Sciences, Center for Cell and Developmental Biology and State Key Laboratory of Agrobiotechnology, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR.
ORCID-Profile: Chi Him Eddie Ma
Förderung
- Innovation and Technology Commission of the Hong Kong Special Administrative Region Government
Zitieren
APA
Kumar, G., Zhou, Z., Wang, Z., Kwan, K. M., Tin, C., & Ma, C. H. E. (2024). Real‐time field‐programmable gate array‐based closed‐loop deep brain stimulation platform targeting cerebellar circuitry rescues motor deficits in a mouse model of cerebellar ataxia. CNS Neuroscience & Therapeutics. https://doi.org/10.1111/cns.14638
Vancouver
Kumar G, Zhou Z, Wang Z, Kwan KM, Tin C, Ma CHE. Real‐time field‐programmable gate array‐based closed‐loop deep brain stimulation platform targeting cerebellar circuitry rescues motor deficits in a mouse model of cerebellar ataxia. CNS Neuroscience & Therapeutics. 2024. doi:10.1111/cns.14638
BibTeX
@article{Kumar2024,
author = {Kumar, Gajendra and Zhou, Zhanhong and Wang, Zhihua and Kwan, Kin Ming and Tin, Chung and Ma, Chi Him Eddie},
title = {Real‐time field‐programmable gate array‐based closed‐loop deep brain stimulation platform targeting cerebellar circuitry rescues motor deficits in a mouse model of cerebellar ataxia},
journal = {CNS Neuroscience & Therapeutics},
year = {2024},
doi = {10.1111/cns.14638}
}
EUVIMED